Toronto Public Health is collaborating with the Toronto Overdose Early Warning and Alert Partnership to provide timely information on overdose activity, with a current focus on opioids. Additional data and indicators may be added to this site as they become available.

Last Updated: February 20, 2019

Toronto Paramedic Services is collaborating with Toronto Public Health to share information on calls for suspected opioid overdoses received by paramedics in Toronto. This includes the number and location of cases where the responding paramedic suspects an opioid overdose. This may differ from the patient’s final diagnosis in hospital or cause of death determined by the coroner. These findings are preliminary and subject to change. Please see the Data Notes tab for more information on these indicators.

New Report: Detailed analysis from the first complete year of data on suspected opioid overdose calls to Toronto Paramedic Services (TPaS) is complete. Trends in Paramedic-Attended Opioid Overdoses: A Review of Suspected Opioid Overdoses in Toronto Paramedic Services Data, 2017/18 contains information on demographics of cases, trends by month, day, and time, and Toronto neighbourhood comparisons.

Since August 7, 2017, Toronto Paramedic Service attended 61 non-fatal and three fatal suspected opioid overdoses per week on average. Fatal cases include those where the patient died on scene and the coroner was notified.

Over this period, an average of 14 non-fatal cases per week had naloxone administered by a community member before paramedic arrival. Paramedics administered naloxone in an average of eight non-fatal cases per week.

Weekly* number of suspected opioid overdose calls received by Toronto Paramedic Services, Toronto, August 7, 2017 to February 17, 2019**Line graph of calls to paramedics for suspected opioid overdoses

Table of calls to paramedics for suspected opioid overdoses by month week

* Weeks are calculated Monday to Sunday and are labelled with the Monday of each week period. Table shows data for the most recent three-month period.** Due to ongoing review of case definition, some weekly numbers of suspected opioid overdose calls have changed slightly from what was posted prior to August 13, 2018.† August 2017 and February 2019 are not complete months’ worth of data. Data are captured for August 2017 starting on August 3, 2017, and for February 2019 up to and including February 17, 2019. Source: Toronto Paramedic Services. Electronic Patient Care Record. [Weekly: August 7, 2017 to February 17, 2019; Monthly: August 3, 2017 to February 17, 2019]. Extracted February 19, 2019.

 

The map shows the distribution of opioid overdose calls received by Toronto Paramedic Services for January 2019. It includes fatal and non-fatal suspected opioid overdoses combined. The map shows the locations where paramedics made contact with patients. Please see the Data Notes tab for more information on these indicators. For more information on the number of calls by neighbourhood and nearest main intersection, please see Calls to Paramedic for Suspected Opioid Overdoses – Geographic Information.

Map of suspected opioid overdose calls received by Toronto Paramedic Services, Toronto, January 2019

Map of suspected opioid overdose calls received by Toronto Paramedic ServicesSource: Toronto Paramedic Services, Electronic Patient Care Record, January 1 to 31, 2019.Extracted February 4, 2019


Contact Us

For information about data sources and indicators Surveillance and Epidemiology Unit

seu@toronto.ca

416-392-7450

For information about naloxone and supervised injection services The Works

theworks@toronto.ca

416-392-0520

For information about the Toronto Overdose Early Warning & Alert Partnership Toronto Drug Strategy

drugstrategy@toronto.ca

416-338-3585

Last Updated: February 20, 2019

Substance-related emergency department visits at Toronto hospitals fluctuated between July 2018 and January 2019, with a slight increase in the last week of January. The number of suspected overdose cases also fluctuated slightly, with a similar trend as substance-related visits. Note that neither of these indicators are specific to opioids. Substance-related emergency department visits may be due to intoxication, addiction, overdose, or withdrawal. Suspected overdose cases are a subset of substance-related visits that specifically mention overdose in the chief complaint and meet a set of inclusion criteria. Please see the Data Notes tab for more information on these indicators.

Number of substance-related emergency department visits and suspected overdose cases by week, Toronto hospitals, June 25, 2018 to February 17, 2019* Line graph of hospital visits for suspected overdose cases

 Table of hospital visits for suspected overdose cases*The date noted indicates the start of the week. Counts are reported from Mondays to Sundays.Source: Acute Care Enhanced Surveillance System. ED Line Listings. June 25, 2018 to February 17, 2019. Extracted February 19, 2019.

 

The number emergency department visits has fluctuated over the past two years with a general upward trend. The largest increase was seen between June and September 2017 followed by a decrease in the fall of 2017. Hospitalizations for opioid poisoning remained relatively stable over the period. Note that changes to hospital reporting for opioid overdoses at the start of May 2017 may account for some of the increase in this indicator. Please see the Data Notes tab for more information on this indicator.

Number of emergency department visits and hospitalizations due to opioid poisoning by month, Toronto hospitals, April 2016 to June 2018

Line graph of Emergency Department visits and Hospitalizations due to opioid poisoningSource for ED visit data: National Ambulatory Care Reporting System, April 2016 to June 2018. Ontario Ministry of Health and Long-Term Care, IntelliHEALTH ONTARIO.  Extracted November 2018.Source for hospitalizations: Discharge Abstracts Database, April 2016 to June 2018. Ontario Ministry of Health and Long-Term Care, IntelliHEALTH ONTARIO. Extracted November 2018.


Contact Us

For information about data sources and indicators Surveillance and Epidemiology Unit

seu@toronto.ca

416-392-7450

For information about naloxone and supervised injection services The Works

theworks@toronto.ca

416-392-0520

For information about the Toronto Overdose Early Warning & Alert Partnership Toronto Drug Strategy

drugstrategy@toronto.ca

416-338-3585

Last Updated: February 21, 2019

In 2017, there were 308 opioid overdose deaths in Toronto. This includes accidental deaths, suicides, and deaths with undetermined intent. This represents a 66% increase in the number of people who died compared to 2016 and a 125% increase compared to 2015. In 2017, 1 in 4 opioid overdose deaths in Ontario occurred in Toronto. Preliminary data for 2018 indicate there were 193* opioid toxicity deaths in Toronto in the first nine months. This number is expected to increase as the cause of death is confirmed for more cases. Please see the Data Notes tab for more information on this indicator.

New data: In May 2017, the Office of the Chief Coroner for Ontario (OCC) began using a new tool to collect information on deaths caused by opioid overdoses in the province of Ontario. Coroners now use the ‘Opioid Investigative Aid’ to gather detailed information about people whose deaths were caused by opioids. Analyses of preliminary data from October 1, 2017 to September 30, 2018 are summarized below the following graph.

Annual number of deaths from opioid toxicity causes, Toronto, 2013 to 2017

Bar graph of number of deaths from opioid toxicity causes by year

Source: Public Health Ontario. Interactive Opioid Tool. 2013 to 2017. Accessed on October 23, 2018.

The numbers reported below are preliminary and subject to change. Only cases that are confirmed by the OCC as opioid toxicity deaths are reported here.  As coroners’ investigations proceed, it is expected that new cases for this time period will be identified, so these numbers may rise in the coming months.

These data represent confirmed opioid toxicity deaths from October 1, 2017 to September 30, 2018. Please refer to the total number of deaths in 2017 in the figure above for the most recent full calendar year’s number (308 deaths).

There were 257* confirmed opioid toxicity deaths among residents of Toronto between October 1, 2017 and September 30, 2018. During this one-year period, the majority of deaths in Toronto (94%) were accidental, compared to 89% in the rest of Ontario. Five percent (5%) of deaths in Toronto were classified as suicide, compared to 9% of deaths in the rest of the province.

Seventy-four (74%) percent of accidental opioid toxicity deaths in Toronto from October 1, 2017 to September 30, 2018 were male. Fifty-two percent (52%) occurred among individuals aged 25 to 44 years.

Accidental opioid toxicity deaths by age group and sex, Toronto, October 1, 2017 to September 30, 2018*

Bar graph of number of accidental opioid toxicity deaths by age group and sex

Among accidental opioid toxicity deaths in Toronto from October 1, 2017 to September 30, 2018, the most common ethno-racial groups include:

  • White (76%)
  • Black (6%)
  • Indigenous (4%)

Fifty percent (50%) of individuals were unemployed at the time of death. However, information on employment status was unknown or missing for 33% of individuals.*

Most (71%) of people who died by accidental opioid toxicity in Toronto resided in a private dwelling at the time of their death. In Toronto, 12% of deceased individuals were experiencing homelessness compared to 9% in the rest of Ontario. There were no deaths among residents of correctional facilities occurring in Toronto. Information on living arrangements was unknown or missing for 6% of individuals.*

Accidental opioid toxicity deaths by living arrangements of the decedent, Toronto compared to the rest of Ontario, October 1, 2017 to September 30, 2018*

Bar graph of percent of accidental opioid toxicity deaths by living arrangement of the decedent, Toronto compared to the rest of Ontario

For the majority (75%) of accidental opioid toxicity deaths in Toronto between October 1, 2017 and September 30, 2018, the overdose occurred in a private residence. This trend was similar in the rest of Ontario.

Accidental opioid toxicity deaths by location of overdose incident leading to death, Toronto, October 1, 2017 to September 30, 2018*

Bar graph of percent of accidental opioid toxicity deaths by location of overdose incident leading to death

In 69% of accidental opioid toxicity deaths occurring between October 1, 2017 and September 30, 2018 in Toronto, the deceased person was at home at the time of the death.  There was evidence of an attempt to resuscitate the deceased individual in 46% of the cases. Fifty-two percent (52%) of deaths occurred without another individual who could intervene at the time of overdose present; however, information was missing in 24% of cases.*

Naloxone use was reported in 22% of accidental opioid toxicity deaths; however, there was missing information in 10% of cases. In 31% of cases where naloxone use was reported, it was administered by bystanders. In 48% of cases, it was used by hospital workers, and in 52% it was by emergency responders.

Fentanyl was the most commonly reported opioid contributing to death. Fentanyl and its analogues were more common contributors to accidental death in Toronto (78%) compared to the rest of Ontario (69%).

Accidental opioid toxicity deaths by type of opioid contributing to death, Toronto, October 1, 2017 to September 30, 2018*,‡, §

Bar graph of percent of accidental opioid toxicity deaths by type of opioid contributing to death* Numbers are preliminary and subject to change.† Individuals with missing and unknown data are included in the denominator for this analysis. Drug categories are not mutually exclusive; some deaths are attributed to multi-drug toxicity where a death can include more than one opioid as a cause.§ The “All fentanyl combined” category includes fentanyl, carfentanil and fentanyl analogues.

Data source: Coroner’s Opioid Investigative Aid, October 1, 2017 to September 30, 2018, Office of the Chief Coroner for Ontario, extracted January 21, 2019.

Contact Us

For information about data sources and indicators Surveillance and Epidemiology Unit

seu@toronto.ca

416-392-7450

For information about naloxone and supervised injection services The Works

theworks@toronto.ca

416-392-0520

For information about the Toronto Overdose Early Warning & Alert Partnership Toronto Drug Strategy

drugstrategy@toronto.ca

416-338-3585

Last Updated: February 20, 2019

On August 21, 2017, Toronto Public Health opened the interim site for supervised injection services at The Works. Services moved to the permanent site on October 30, 2017.

Supervised injection services are health services that provide a hygienic environment for people to inject pre-obtained drugs under the supervision of a trained health care professional. In addition to supervised injection, individuals are provided with sterile injection supplies, education on safer injection, overdose prevention and intervention, medical and counselling services, and referrals to drug treatment, housing, income support and other services. Please see the Data Notes tab for more information on these indicators.

As of February 17, 2019, there were 35,887 visits to the supervised injection service. There were 662 visits where an overdose occurred, including 236 visits where the client required naloxone.

Weekly visits to the supervised injection service, The Works, August 21, 2017 to February 17, 2019*,†,

 Graph of visits to the supervised injection service

Monthly number of visits to the supervised injection visits, The Works, August 21, 2017 to February 17, 2019§.

Table of visits to the supervised injection service

* Before October 14, 2018, weeks were calculated Monday to Saturday. As of October 14, 2018, the supervised injection service is also open on Sundays, weeks are now calculated Monday to Sunday and are labeled with the Monday of each week period.† Due to an ongoing review, data currently presented are preliminary and subject to change. Some weeks include reduced hours due to holiday schedules.§ August 2017 and February 2019 are not complete months’ worth of data. Data are captured for August of 2017 starting on August 21, 2017. Data are captured for February of 2019 up to and including February 17, 2019.
Sources: NEO database & The Works – Toronto Public Health. Extracted February 19, 2019.

 

Contact Us

For information about data sources and indicators Surveillance and Epidemiology Unit

seu@toronto.ca

416-392-7450

For information about naloxone and supervised injection services The Works

theworks@toronto.ca

416-392-0520

For information about the Toronto Overdose Early Warning & Alert Partnership Toronto Drug Strategy

drugstrategy@toronto.ca

416-338-3585

Last Updated: February 6, 2019

Indicators of opioid prescribing in Ontario can be accessed from the interactive Prescription Opioid Tool. This tool uses data from the Narcotics Monitoring System to provide information on opioid prescriptions from retail pharmacies in Ontario.

The weekly number of new admissions to Toronto-based treatment centres fluctuated over the past year with no clear pattern emerging. Please see the Data Notes tab for more information on this indicator.

Number of weekly new admissions to provincially-funded drug treatment centres by presenting problem substance, Toronto, January 8, 2018 to January 6, 2019

Line graph of admissions to drug treatment centres in Toronto

Source: Centre for Addiction and Mental Health. Drug and Alcohol Treatment Information System. January 8, 2018 to January 6, 2019. Extracted February 5, 2019.


Contact Us

For information about data sources and indicators Surveillance and Epidemiology Unit

seu@toronto.ca

416-392-7450

For information about naloxone and supervised injection services The Works

theworks@toronto.ca

416-392-0520

For information about the Toronto Overdose Early Warning & Alert Partnership Toronto Drug Strategy

drugstrategy@toronto.ca

416-338-3585

15/01/2018: Survey on Opioid Awareness (2017) Results
Statistics Canada has released results from the Survey on Opioid Awareness. The survey found that 29% of Canadians aged 18 years and older reported using some form of opioids in the past five years. It also found that 78% of Ontarians were ‘very aware’ or ‘somewhat aware’ of the opioid issue. For more information see the full results and infographicPlease note that Toronto-specific statistics are not available

29/05/2017: Interactive tool on opioid-related harms data
Public Health Ontario recently released an interactive tool that explores trends in opioid-related emergency department visits, hospitalizations and deaths from 2003 to 2015 in Ontario. Toronto Public Health has created a summary document that reviews the key findings for Toronto.

Please note that the interactive tool and summary document capture outcomes occurring among Toronto residents only and as such, will include fewer occurrences than those included on this website (which capture all overdose outcomes occurring in Toronto, regardless of where an individual resides).

28/03/2017: Toronto Overdose Action Plan

Toronto Public Health worked with community partners to develop the Toronto Overdose Action Plan: Prevention & Response, which was endorsed by the Board of Health on March 20, 2017. The Plan includes a comprehensive set of actions for all orders of government to prevent and respond to drug overdoses.

28/03/2017: Naloxone information

The Province of Ontario has launched a new website with information on where to get free naloxone kits in your area.


Contact Us

For information about data sources and indicators Surveillance and Epidemiology Unit

seu@toronto.ca

416-392-7450

For information about naloxone and supervised injection services The Works

theworks@toronto.ca

416-392-0520

For information about the Toronto Overdose Early Warning & Alert Partnership Toronto Drug Strategy

drugstrategy@toronto.ca

416-338-3585

Paramedic Response

Weekly number of suspected opioid overdose calls received by Toronto Paramedic Services, Toronto

Source: Toronto Paramedic Services. Paramedic Electronic Patient Care Record.

Data Notes:

  • This indicator is preliminary and subject to change pending further review of the data source.
  • This indicator includes cases where the responding paramedic suspects an opioid overdose. This may differ from the final diagnosis in hospital or cause of death determined by the coroner.
  • Fatal cases includes those where the patient died on scene and the coroner was notified. Patients who die after being transported to hospital may be miscategorized here as ‘non-fatal’ cases.
  • This indicator includes only instances where 911 is called and underestimates the true number of overdoses in the community.

Map of suspected opioid overdose calls received by Toronto Paramedic Services, Toronto

Source: Toronto Paramedic Services. Paramedic Electronic Patient Care Record.

Data Notes:

  • This indicator is preliminary and subject to change pending further review of the data source.
  • The map shows the locations where paramedics made contact with patients, which may or may not be the same location from which 911 was called.
  • The colours of the heat map indicate the relative density, defined as the number of cases per unit area. As a stretch legend is used to visualize the density, this map should not be interpreted in absolute terms when compared to heat maps from other time periods.
  • Suspected opioid overdoses occurring slightly outside the City of Toronto boundaries were excluded from the map.
  • This indicator includes cases where the responding paramedic suspects an opioid overdose. This may differ from the final diagnosis in hospital or cause of death determined by the coroner.
  • This indicator includes only instances where 911 is called and underestimates the true number of overdoses in the community.

Hospital Visits

Number of substance-related emergency department visits by week, Toronto hospitals

Source: Acute Care Enhanced Surveillance System. ED Line Listings.

Data Notes:

  • This data source only captures substance-related visits that result in an individual seeking care in a hospital setting. This is likely an underestimation of the true burden of overdose in the population.
  • ACES is a syndromic surveillance system that classifies visits and admissions into ‘syndromes’ using algorithms to assess and classify open text from the chief compliant recorded at triage or registration. This process allows ACES to provide daily counts of visits and admissions.
  • This data sources captures visits to acute care facilities in Toronto. However, it does not currently capture visits to Sunnybrook hospital. Moreover specialty hospitals, such as the Women’s College Hospital are not captured. Visits to the Centre for Addiction and Mental Health are included in ACES as of November 23, 2017.
  • ‘Substance-related visits’ include instances of intoxication, addiction, overdose, or withdrawal.
  • ‘Substance-related visits’ include those caused by opioids or non-opioid related drugs (OPI and TOX syndromes, combined). It excludes those related to alcohol.
  • This indicator includes all visits to Toronto hospitals, regardless of whether or not the individual resides in Toronto.
  • Monday to Sunday week units are used here as the unit of analysis, with the starting date of each week labeled on the x-axis of the graph.

Number of emergency department visits due to suspected overdoses by week, Toronto hospitals

Source: Acute Care Enhanced Surveillance System. ED Line Listings.

Data Notes:

  • This indicator is only available from May 2017 onwards, due to availability of data.
  • This data source only captures suspected overdoses that result in an individual seeking care in a hospital setting. This is likely an underestimation of the true burden of overdose in the population.
  • ACES is a syndromic surveillance system that classifies visits and admissions into ‘syndromes’ using algorithms to assess and classify open text from the chief compliant recorded at triage or registration. This process allows ACES to provide daily counts of visits.
  • ‘Suspected overdoses’ refer to a subset of substance-related visits that specifically reference ‘overdose’ in the chief complaint. It excludes overdoses that specify a substance of non-interest (e.g. alcohol, over-the-counter medication, prescription drugs of non-interest such as blood pressure medication, and toxic products such as cleaning products).
  • ‘Suspected overdoses’ include only visits with a Canadian Triage Acuity Score of 1 (Resuscitation), 2 (Emergency), or missing.
  • ‘Suspected overdoses’ excludes visits to children less than 10 years of age.
  • For the majority of visits, the substance causing overdoses is not specified. It is important to note that this indicator measures overdoses from all types of substances, not just opioids.
  • ‘Suspected overdoses’ also excludes intentional overdoses or those related to self-harm.
  • This data sources captures visits to acute care facilities in Toronto. However, it does not currently capture visits to Sunnybrook hospital. Moreover specialty hospitals, such as Women’s College Hospital are not captured. Visits to the Centre for Addiction and Mental Health are included in ACES as of November 23, 2017.
  • This indicator includes all visits to Toronto hospitals, regardless of whether or not the individual resides in Toronto.
  • Monday to Sunday week units are used here as the unit of analysis, with the starting date of each week labeled on the x-axis of the graph.

Number of emergency department visits due to opioid poisoning by month, Toronto hospitals

Source: National Ambulatory Care Reporting System. Ontario Ministry of Health and Long-Term Care, IntelliHEALTH ONTARIO.

Data Notes:

  • This data source also only captures overdoses where patients visited the emergency department. It is likely these data underrepresents the true burden of overdose in the population.
  • This data source includes all visits to Toronto hospitals, including those who are residents of other municipalities accessing care in Toronto.
  • Opioid poisonings were measured using ICD-10 codes: T40.0 – Opium, T40.1 – Heroin, T40.2 – Other opioids (e.g. Codeine, Morphine), T40.3 – Methadone, T40.4 – Other synthetic narcotics (Pethidine) and T40.6 – Poisoning by other and unspecified narcotics.
  • This indicator include visits where opioid poisoning was listed as a main or a contributing cause.
  • Emergency department visits includes only unscheduled visits.

Number of hospitalizations due to opioid poisoning by month, Toronto hospitals

Source: Discharge Abstracts Database. Ontario Ministry of Health and Long-Term Care, IntelliHEALTH ONTARIO.

Data Notes:

  • This data source also only captures overdoses where patients were hospitalized. It is likely these data underrepresents the true burden of overdose in the population.
  • This data source includes all hospitalizations to Toronto hospitals, including those who are residents of other municipalities accessing care in Toronto.
  • Opioid poisonings were measured using ICD-10 codes: T40.0 – Opium, T40.1 – Heroin, T40.2 – Other opioids (e.g. Codeine, Morphine), T40.3 – Methadone, T40.4 – Other synthetic narcotics (Pethidine) and T40.6 – Poisoning by other and unspecified narcotics.
  • This indicator includes hospitalizations where opioid poisoning was listed as a main or a contributing cause.
  • In the May 2017 update of this indicator, the data source was changed from the National Ambulatory Care Reporting System to the Discharge Abstracts Database to be consistent with how Public Health Ontario is measuring this indicator. The Discharge Abstracts Database also contains more detailed information about hospitalizations, as records include all information available at the time of discharge which is often more specific than information available at admission.

Deaths

Annual number of deaths from opioid toxicity causes, Toronto

Source: Public Health Ontario. Interactive Opioid Tool. 2013 to 2017. Accessed on October 23, 2018.

  • These data include all manners of death from opioid toxicity (i.e. accidental and intentional) combined.
  • The deaths included here are caused by opioid toxicity, with or without other drugs also contributing to death.
  • Deaths due to chronic substance use, medical assistance in dying, homicides and trauma where an intoxicant contributed to the circumstances of the injury are excluded.

Opioid toxicity death data from the Opioid Investigative Aid

Source: Coroner’s Opioid Investigative Aid, October 1, 2017 to September 30, 2018, Office of the Chief Coroner for Ontario (OCC), extracted January 21, 2019.

Data Notes:

  • These data only include confirmed opioid-related deaths for which an investigation has identified an opioid as directly contributing to the cause of death. The numbers reported are preliminary and subject to change. As coroners’ investigations proceed, it is expected that new cases for this time period will be identified.
  • The deaths included here are caused by opioid toxicity, with or without other drugs also contributing to death.
  • Deaths due to chronic substance use, medical assistance in dying, homicides and trauma where an intoxicant contributed to the circumstances of the injury are excluded.
  • The OCC implemented the Opioid Investigative Aid in May of 2017. The detailed information resulting from this tool are not available prior to this date.
  • Deaths have been assigned to Toronto based on the six-digit postal code of the residence of the deceased. If the postal code of the residence was not available, the postal code of the incident location was used. If this information was not available, the postal code of the death location was used.
  • Gender is based on gender identity at time of death.
  • Ethnicities include White, Indigenous (First Nations, Métis, Inuit), Black, Latin American, South Asian (East Indian, Pakistani, Sri Lankan), all other ethnic groups combined (Chinese, Filipino, Arab, Southeast Asian (Vietnamese, Cambodian, Malaysian), West Asian (Iranian, Afghan), Korean, Japanese, Other), and unknown; groupings were based on frequency of occurrence in the data as of the report creation date.
    • The “Other” category for ethno-racial groups represented 6% of all accidental opioid toxicity deaths in Toronto; other ethnicities are unknown or suppressed due to low numbers
  • Living arrangement categories include:
    • Private dwelling – a separate set of living quarters designed for or converted for human habitation. Must include a source of heat or power and must be an enclosed space that provides shelter/protection from the elements. In Toronto, this includes community housing units
    • Homeless – without stable, permanent, appropriate housing, or the immediate prospect, means and ability of acquiring it; includes no fixed address and those temporarily residing in shelters
    • Collective dwelling – lodging and rooming houses, hotels, motels, tourist establishments, campgrounds and parks, sober living facilities, school residences and training centre residences, work camps, religious establishments, military bases, commercial vessels
  • Incident location categories include:
    • Indoors (private residence) – apartments, condominium, row house/townhouse, rural/agricultural: residential, trailer/mobile home, single-detached house, semi-detached house. In Toronto, this includes community housing.
    • Indoors (public) – includes airports, public bathrooms, commercial/retail buildings, recreational buildings, and other public buildings
    • Indoors (other) – hotel/motel/inn, rooming house, shelter, and supported living facilities
  • An individual is considered to have died at home if the location of death address is the same as the decedent’s home address
  • Emergency Responders refer to EMS, Police and Fire

Supervised Injection Services

Weekly indicators for the interim supervised injection services, The Works

Source: The Works – Toronto Public Health. Supervised Injection Services.

Data Notes:

  • Numbers are preliminary and subject to change.
  • Number of visits refers to the number of clients visiting the supervised injection services (SIS). This includes all visits to the SIS, regardless of whether the client injected. Visits may be from repeat clients.
  • Number of overdoses refers to the number of visits resulting in an overdose event that occurs within the site or that occurs to a client who has injected at the site, as reported by the manager at The Works. This does not refer to unique clients.
  • Number of naloxone administrations refers to the number of visits resulting in a naloxone administration. Note that multiple doses of naloxone may be administered during one overdose event.

Treatment

Weekly new admissions to provincially-funded drug treatment centres by presenting problem substance, Toronto

Source: Drug and Alcohol Treatment Information System. Centre for Addiction and Mental Health.

Data Notes:

  • This indicator captures new admissions to treatment centres in Toronto only.
  • Individuals who access addiction treatment services through primary care, hospitals, private clinics and federally-funded First Nations health service providers are not included in this indicator.
  • Presenting problem substances are self-reported by clients. Individuals can list up to 5 substances upon admission.
  • Individuals who specify multiple presenting problem substances are counted as a new admission for each type of substance. For instance, if an individuals specifies heroin and prescription opioids as presenting problem substances, they will be counted as a new admission for both heroin and prescription opioids.
  • Completeness of this indicator is limited by timeliness of what is submitted by health service providers. This can vary from provider to provider. Counts for recent weeks may be subject to change, as more service providers complete their reporting.

Contact Us

For information about data sources and indicators Surveillance and Epidemiology Unit

seu@toronto.ca

416-392-7450

For information about naloxone and supervised injection services The Works

theworks@toronto.ca

416-392-0520

For information about the Toronto Overdose Early Warning & Alert Partnership Toronto Drug Strategy

drugstrategy@toronto.ca

416-338-3585